sRAGE

Baseline plasma sRAGE levels identify differential mortality benefits from lung recruitment in ARDS, enabling personalized ventilation strategies unlike inflammatory phenotyping. High sRAGE patients benefit from recruitment maneuvers, while low sRAGE patients face increased risk.